Nafresha Abuaun
Psychiatric/Mental Health · Dayton, OHNPI 1235783390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 487 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 487 payments — averaging $25.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Otsuka America Pharmaceutical, Inc.$2K
- Johnson & Johnson$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Vanda Pharmaceuticals Inc.$870
- Alkermes, Inc.$689
- plus $3K from 12 others
What the payments were for
- Food & beverage$12,581100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 137 | $2,636 |
| Otsuka America Pharmaceutical, Inc. | 95 | $2,485 |
| Johnson & Johnson | 37 | $1,573 |
| Teva Pharmaceuticals USA, Inc. | 33 | $1,228 |
| Vanda Pharmaceuticals Inc. | 43 | $870 |
| Alkermes, Inc. | 25 | $689 |
| E.r. Squibb & Sons, L.L.C. | 21 | $528 |
| Lundbeck LLC | 30 | $492 |
| Axsome Therapeutics, Inc. | 25 | $479 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $448 |
| Neurocrine Biosciences, Inc. | 13 | $338 |
| Sunovion Pharmaceuticals Inc. | 11 | $260 |
| Validus Pharmaceuticals LLC | 2 | $256 |
| Braeburn Inc. | 1 | $123 |
| Gilead | 1 | $100 |
| Corium, LLC | 2 | $45 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$927
- AUSTEDO$477
- VRAYLAR$449
- SPRAVATO$350
- Equetro$256
- CAPLYTA$252
- ABILIFY MAINTENA$249
- COBENFY$230
- Austedo XR$226
- ABILIFY ASIMTUFII$125
- REXULTI$124
- BRIXADI$123
- INGREZZA$105
How this compares
$12,581 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 39 | $55,460 |
| Aripiprazole | 55 | $7,706 |
| Lurasidone Hcl | 13 | $2,819 |
| Bupropion XlBupropion Hcl | 100 | $1,839 |
| Quetiapine Fumarate | 65 | $1,415 |
| Hydroxyzine Hcl | 64 | $1,385 |
| Duloxetine Hcl | 38 | $1,055 |
| Olanzapine | 19 | $973 |
| Buspirone Hcl | 66 | $611 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $593 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $587 |
| Doxepin Hcl | 12 | $317 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $266 |
| Propranolol Hcl | 22 | $256 |
| Amitriptyline Hcl | 13 | $223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $2,636 | $55,46039 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Dayton
- Steven MatesDayton$121K
- Yvonne ClarkDayton$10K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.